P

Inventor

FUCHSS THOMAS

DE26 patents
⚠️ This page may combine multiple inventors who share the name “FUCHSS THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK PATENT GMBH

14 patents
US10383874B2Aug 20, 2019

Arylquinazolines

MERCK PATENT GMBH4 citations84
US10172859B2Jan 8, 2019

Arylquinazolines

MERCK PATENT GMBH4 citations84
US9732094B2Aug 15, 2017

Arylquinazolines

MERCK PATENT GMBH4 citations84
US11065253B2Jul 20, 2021

Arylquinazolines

MERCK PATENT GMBH1 citations73
US10457677B2Oct 29, 2019

Imidazolonylquinolines and the use thereof as ATM kinase inhibitors

MERCK PATENT GMBH3 citations73
US9670142B2Jun 6, 2017

1,3-diaminocyclopentane carboxamide derivatives

MERCK PATENT GMBH4 citations72
US11608338B2Mar 21, 2023

Imidazolonylquinolines and the use thereof as ATM kinase inhibitors

MERCK PATENT GMBH0 citations62
US10975075B2Apr 13, 2021

Imidazolonylquinolines and the use thereof as ATM kinase inhibitors

MERCK PATENT GMBH0 citations62
US11103512B2Aug 31, 2021

Crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol

MERCK PATENT GMBH1 citations58
US11053233B2Jul 6, 2021

Solid form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol

MERCK PATENT GMBH1 citations58
US12344604B2Jul 1, 2025

Imidazolonylquinoline compounds and therapeutic uses thereof

MERCK PATENT GMBH0 citations57
US10745399B2Aug 18, 2020

Imidazolonylquinolines and the use thereof as ATM kinase inhibitors

MERCK PATENT GMBH0 citations52
US9718785B2Aug 1, 2017

1,3-Disubstituted cyclopentane derivatives

MERCK PATENT GMBH0 citations41
US9187469B2Nov 17, 2015

Morpholinylbenzotriazines for use in cancer therapy

MERCK PATENT GMBH0 citations41

ALTANA PHARMA AG

5 patents

FUCHSS THOMAS

4 patents

MEDERSKI WERNER

1 patent

MERCK PATENT GES MIT BESCHRANKTER HAFTUNG

1 patent

NYCOMED GMBH

1 patent